Nomenclature for antiviral‐resistant human hepatitis B virus mutations in the polymerase region
Lieven J. Stuyver, Stephen A. Locarnini, Anna Lok, Douglas D. Richman, William F. Carman, Jules L. Dienstag, Raymond F. Schinazi – 30 December 2003 – There is currently no universally accepted numbering convention for the antiviral drug‐related resistance mutations in the reverse transcriptase (rt) domain of the human hepatitis B virus (HBV) polymerase. The published inconsistencies have resulted from different HBV genotypes. A standardized numbering system for HBV polymerase is proposed.